# A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL)

> **NCT00302861** · PHASE1,PHASE2 · TERMINATED · sponsor: **Genitope Corporation** · enrollment: 86 (—)

## Conditions studied

- B-Cell Chronic Lymphocytic Leukemia

## Interventions

- **BIOLOGICAL:** MyVax

## Key facts

- **NCT ID:** NCT00302861
- **Lead sponsor:** Genitope Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 86 (—)
- **Last updated:** 2008-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00302861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00302861, "A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL)". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00302861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*